Nuvalent, Inc.NUVLNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
3.62%
↓ 77% below average
Average (22q)
15.98%
Historical baseline
Range
High:56.27%
Low:-3.80%
Volatility
375.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 3.62% |
| Q2 2025 | 8.73% |
| Q1 2025 | 7.20% |
| Q4 2024 | 14.65% |
| Q3 2024 | 23.16% |
| Q2 2024 | 27.26% |
| Q1 2024 | 8.57% |
| Q4 2023 | 20.17% |
| Q3 2023 | 14.23% |
| Q2 2023 | 17.16% |
| Q1 2023 | -3.19% |
| Q4 2022 | 56.27% |
| Q3 2022 | 7.87% |
| Q2 2022 | 6.81% |
| Q1 2022 | -3.80% |
| Q4 2021 | 45.71% |
| Q3 2021 | 15.70% |
| Q2 2021 | 42.71% |
| Q1 2021 | 16.71% |
| Q4 2020 | 26.28% |
| Q3 2020 | 1.75% |
| Q2 2020 | 9.95% |
| Q1 2020 | 0.00% |